Recent Updates
Recently added Catalysts
CELC Positive Sentiment

Celcuity Inc. Schedules Release of Second Quarter 2025 Financial Results and Webcast/Conference Call

Thursday, August 7, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Celcuity Inc., a clinical-stage biotechnology company, has announced the release of its financial results for the second quarter of 2025, which will occur after market close on August 14, 2025. Management will also host a webcast and teleconference at 4:30 p.m. Eastern Time on the same day to discuss the financial results and provide a corporate update. This event is expected to enhance transparency with stakeholders and offer insights into the company's progress.
Price reaction · baseline $44.19 (2025-08-06 close) · hit after-hours · clean, no other CELC news in the window
day 0 close · peak
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Celcuity is actively moving forward with financial reporting.
  • The upcoming webcast may provide valuable corporate updates.
  • Scheduled communication supports transparency and shareholder engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+27%
120-day peak, hindsight
Typical move
14.9%
average across 6 past catalysts
Cash runway
~41 mo
Minimal dilution risk
Lead asset
Gedatolisib
Phase 3 · Breast Cancer

Full Press Release Details

MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the second quarter 2025 after the market closes on Thursday, August 14, 2025. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.
Webcast and Conference Call Information
To participate in the teleconference, domestic callers should dial 1-800-717-1738 and international callers should dial 1-646-307-1865. A live webcast presentation can also be accessed using this weblink: https://viavid.webcasts.com/starthere.jsp?ei=1726762&tp_key=047c56f7b8. A replay of the webcast will be available on the Celcuity website following the live event.
View source version of release on GlobeNewswire.com

Frequently Asked Questions

When will Celcuity release its Q2 2025 financial results?

Celcuity will release its Q2 2025 financial results on August 14, 2025.

What time is the Celcuity webcast on August 14, 2025?

The Celcuity webcast will take place at 4:30 p.m. Eastern Time.

How can I access the Celcuity webcast?

You can access the webcast via the provided link: https://viavid.webcasts.com/starthere.jsp?ei=1726762&tp_key=047c56f7b8.

How do I join the Celcuity teleconference?

Domestic callers can dial 1-800-717-1738 and international callers should dial 1-646-307-1865.

Will there be a replay of the webcast available?

Yes, a replay of the webcast will be available on the Celcuity website after the event.

ShareAdd on Google
Tags: CELC Viatris Investor Conferences Healthcare Celcuity cellular therapies oncology financial results Q2 2025
Last updated: Aug 7, 2025

Biotech snapshot

Cash runway
$754M liquidity · $18M/mo burn
~41 mo
Minimal dilution risk
Lead asset
GedatolisibPhase 3
Breast Cancer →

Catalyst track record

+27%
best trade around CELC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CELC.

See every catalyst's timing & PoA →